Tested Applications
| Positive WB detected in | HEK-293T cells |
| Positive IHC detected in | mouse liver tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:1000 |
| Immunohistochemistry (IHC) | IHC : 1:200-1:800 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
26087-1-AP targets UFL1 in WB, IHC, IF, IP, ELISA applications and shows reactivity with human, mouse samples.
| Tested Reactivity | human, mouse |
| Cited Reactivity | human, mouse, bovine |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag23404 Product name: Recombinant human KIAA0776 protein Source: e coli.-derived, PET28a Tag: 6*His Domain: 1-350 aa of BC036379 Sequence: MADAWEEIRRLAADFQRAQFAEATQRLSERNCIEIVNKLIAQKQLEVVHTLDGKEYITPAQISKEMRDELHVRGGRVNIVDLQQVINVDLIHIENRIGDIIKSEKHVQLVLGQLIDENYLDRLAEEVNDKLQESGQVTISELCKTYDLPGNFLTQALTQRLGRIISGHIDLDNRGVIFTEAFVARHKARIRGLFSAITRPTAVNSLISKYGFQEQLLYSVLEELVNSGRLRGTVVGGRQDKAVFVPDIYSRTQSTWVDSFFRQNGYLEFDALSRLGIPDAVSYIKKRYKTTQLLFLKAACVGQGLVDQVEASVEEAISSGTWVDIAPLLPTSLSVEDAAILLQQVMRAFS Predict reactive species |
| Full Name | KIAA0776 |
| Observed Molecular Weight | 80 kDa; 100 kDa |
| GenBank Accession Number | BC036379 |
| Gene Symbol | KIAA0776 |
| Gene ID (NCBI) | 23376 |
| RRID | AB_2880370 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | O94874 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Protocols
| Product Specific Protocols | |
|---|---|
| IHC protocol for UFL1 antibody 26087-1-AP | Download protocol |
| WB protocol for UFL1 antibody 26087-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
Anti-UFL1 antibody (Cat# 26087-1-AP) has 17 citations published in journals including Signal Transduction and Targeted Therapy, Molecular Cell, EMBO Journal, Cancer Letters, Free Radical Biology and Medicine, Oxidative Medicine and Cellular Longevity, Cell Death & Disease, and others. Research fields span UFMylation biology, cancer (glioblastoma, hepatocellular carcinoma, pancreatic cancer), inflammation, apoptosis, lipid metabolism, ER stress, autophagy, pyroptosis, and antibacterial immunity.
| Species | Application | Title |
|---|---|---|
Signal Transduct Target Ther Dual-targeting pharmacological UFMylation inhibition reprograms tumor and immune microenvironments to achieve long-term glioblastoma regression. | ||
J Adv Res Panaxatriol exerts anti-senescence effects and alleviates osteoarthritis and cartilage repair fibrosis by targeting UFL1 | ||
Mol Cell An Epstein-Barr virus protein interaction map reveals NLRP3 inflammasome evasion via MAVS UFMylation | ||
Cell Death Dis The RASSF1C-HIF-1α axis drives macrophage lipid metabolism to promote pancreatic cancer. | ||
Cancer Lett CDK5RAP3 is a novel super-enhancer-driven gene activated by master TFs and regulates ER-Phagy in neuroblastoma | ||
Cancer Lett DysUFMylation reprograms immunosuppressive neutrophils to potentiate anti-PD-1 therapy in hepatocellular carcinoma.
|





